Reviews raise questions over delirium treatments
Current evidence does not support the use of second-generation antipsychotics or haloperidol to treat or prevent delirium in adult inpatients, two studies show.
US researchers included 16 randomised controlled trials and 10 observational studies of hospitalised adults with delirium in their first systematic review.
There was no difference in sedation status between haloperidol and second-generation antipsychotics versus placebo.
Nor were there differences in delirium duration, hospital length of stay or mortality, they